Clinical Trial Update: Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of REOLYSIN in combination with paclitaxel and carboplatin for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Carcinoma, Squamous Cell of the Head and Neck | Phase 2 | Status: COMPLETED